Effect of Percutaneous Coronary Intervention on Heart Rate Variability in Coronary Artery Disease Patients

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare:

For permissions and non-commercial reprint enquiries, please visit to start a request.

For author reprints, please email
Average (ratings)
No ratings
Your rating


Patients with coronary artery disease (CAD) have a state of autonomic imbalance with a sympathetic predominance. Autonomic dysfunction has been linked to an increased risk of cardiovascular morbidity and mortality. Heart rate variability (HRV) analysis is one of the most encouraging non-invasive diagnostic models and is increasingly used for the assessment of autonomic dysfunction. Percutaneous coronary intervention (PCI) is considered the gold standard in CAD treatment. Revascularisation through PCI eliminates the state of sympathetic hyperactivity, restores the normal cardiac autonomic modulation that can be assessed by HRV measurement.

Disclosure:The author has no conflict of interest to declare.



Acknowledgements:The author would like to thank Prof Dr Moustafa Nawar, Prof Dr Mohammed Ahmed Sadaka, Faculty of Medicine, Alexandria University, Alexandria, Egypt; and Dr Moataz Ahmed Zaki, Medical Research Institute, Alexandria University, Alexandria, Egypt.

Correspondence Details:Mahmoud Hassan Abdelnaby, Cardiology and Angiology Unit, Clinical and Experimental Internal Medicine Department, Medical Research Institute, Alexandria University, 165 El-Horeya Rd, Al Ibrahimeyah Qebli WA Al Hadrah Bahri, Qesm Bab Sharqi, Alexandria, Egypt. E:

Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

Coronary artery disease (CAD) is the most common cause of morbidity and premature mortality globally,1 and cardiac autonomic dysfunction is one of the risk factors for CAD.2 Heart rate variability (HRV) is the physiological phenomenon of variation in the time interval between heartbeats and is one of the most promising non-invasive diagnostic methods for assessing autonomic dysfunction.

HRV measurement can efficiently reflect the activity of both sympathetic and vagal components of the autonomic nervous system on the sinus node of the heart.3 It is well established that reduced HRV is an independent predictor of sudden cardiac death in congestive heart failure, poorer outcomes for survivors of acute MI (AMI), and increased cardiovascular risk in people with diabetes.4–7

Effect of Coronary Revascularisation in the Restoration of Normal Autonomic Balance

Patients with CAD and exercise-induced angina have a state of autonomic dysfunction in the form of sympathetic overstimulation, which is considered to be triggered by myocardial ischaemia.8 Many studies have linked CAD to reduced HRV even in the absence of heart failure or previous MI.2,9 Theoretically, coronary revascularisation in CAD patients by percutaneous coronary intervention (PCI) could restore the normal autonomic balance, which can be proved and quantified by HRV measurement.

This theory has been proved in several trials. Bonnemeier et al. assessed the effect of successful reperfusion by primary PCI on HRV after AMI.10 The principal conclusion of the study was that early reperfusion in AMI resulted in a significant recovery of HRV parameters, which indicates vagal activation and sympathetic withdrawal. HRV was significantly lower in patients undergoing late perfusion compared with those with early reperfusion. Early reperfusion has a beneficial effect by normalisation of HRV, reflecting attenuation of cardiac autonomic impairment that yields a better outcome after AMI.

Sedziwy et al. studied HRV time domains in patients before PCI and during a 1-year follow-up after PCI using serial 24-hour Holter monitoring.11 They concluded that successful revascularisation using PCI led to a significant improvement in HRV autonomic balance.

Aydinlar et al. investigated the effect of PCI on QT dispersion and HRV in patients with single-vessel CAD who underwent elective PCI.12 They concluded that HRV parameters significantly improved after PCI. Abrootan et al. studied changes in HRV parameters after elective PCI in patients with stable angina pectoris showing that short-term HRV parameters improved 24 hours after PCI.8 Thes two studies show that PCI is associated with an improved autonomic modulation and overall survival in CAD patients.

Current Limitations of Using Heart Rate Variability in Clinical Practice

Despite several published experimental and clinical trials of HRV measurement, the use of HRV is limited to research and not routinely used in daily clinical practice.9 This can be explained by several factors.

The clinical application of HRV assessment is limited by the lack of standard methods and the variability of parameters such as gender, age, drug interferences and concomitant diseases. There is still no consensus about the most accurate HRV parameter for clinical usage. The sensitivity, specificity and positive predictive accuracy of HRV in risk stratification are still limited. Notably, its positive predictive accuracy is modest, ranging from 14 % to 40 %. However, it has a higher negative predictive value, ranging from 77 % to 98 %.9 Conflicting data suggest that it may be insufficient by itself for adequate risk stratification in high-risk patients. The combination of HRV with other risk stratification methods, including left ventricular ejection fraction, non-sustained ventricular tachycardia, and baroreceptor sensitivity may increase the overall predictive accuracy.13,14


HRV is one of the most promising methods for detection and quantification of autonomic dysfunction. Further research is required for further validation of its effectiveness in clinical usage and its usefulness in risk stratification and as an independent prognostic factor for CAD.


  1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J 2014;35:2950–9.
    Crossref | PubMed
  2. Feng J, Wang A, Gao C, Zet al. Altered heart rate variability depend on the characteristics of coronary lesions in stable angina pectoris. Anatol J Cardiol 2015;15:496–501.
    Crossref | PubMed
  3. Sztajzel J. Heart rate variability: a noninvasive electrocardiographic method to measure the autonomic nervous system. Swiss Med Wkly 2004;134:514–22.
  4. Musialik-Łydka A, Sredniawa B, Pasyk S. Heart rate variability in heart failure. Kardiol Pol 2003;58:14–6.
  5. Buccelletti E, Gilardi E, Scaini E, et al. Heart rate variability and myocardial infarction: systematic literature review and metanalysis. Eur Rev Med Pharmacol Sci 2009;13:299–307.
  6. Futterman L, Lemberg L. Heart rate variability: prognostic implications. Am J Crit Care 1994;3:476–80.
  7. Markuszewski L, Bissinger A. Application of heart rate variability in prognosis of patients with diabetes mellitus. Pol Merkur Lekarski 2005;19:548–52 [in Polish].
  8. Abrootan S, Yazdankhah S, Payami B, Alasti M. Changes in heart rate variability parameters after elective percutaneous coronary intervention. J Tehran Heart Cent 2015;10:80–4.
  9. Pivatelli FC, Dos Santos MA, Fernandes GB, et al. Sensitivity, specificity and predictive values of linear and nonlinear indices of heart rate variability in stable angina patients. Int Arch Med 2012;5:31.
    Crossref | PubMed
  10. Bonnemeier H, Hartmann F, Wiegand UK, et al. Heart rate variability in patients with acute myocardial infarction undergoing primary coronary angioplasty. Am J Cardiol 2000;85:815–20.
    Crossref | PubMed
  11. Sedziwy E, Olszowska M, Tracz W, Pieniazek P. Heart rate variability in patients treated with percutaneous transluminal coronary angioplasty. Przegl Lek 2002;59:695–8 [in Polish].
  12. Aydinlar A, Sentürk T, Ozdemïr B, et al. Effect of percutaneous transluminal coronary angioplasty on QT dispersion and heart rate variability parameters: cardiovascular topics. Cardiovasc J Africa 2009;20:240–4.
  13. Odemuyiwa O, Farrell TG, Malik M, et al. Influence of age on the relation between heart rate variability, left ventricular ejection fraction, frequency of ventricular extrasystoles, and sudden death after myocardial infarction. Br Heart J 1992;67:387–91.
    Crossref | PubMed
  14. Farrell TG, Bashir Y, Cripps T, et al. Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol 1991;18:687–97.
    Crossref | PubMed